Byannli
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Byannli, covering 2024-07-22 to 2026-06-10. Get the full timeline:
Most recent: EMA Authorised: Byannli (previously Paliperidone Janssen-Cilag International) (paliperidone palmitate) — Janssen-Cilag International N.V.